Teva Pharmaceutical Industries Limited (TLV:TEVA)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
5,595.00
-95.00 (-1.67%)
Jul 31, 2025, 5:24 PM IDT

TLV:TEVA Ratios and Metrics

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
60,25191,08142,14635,61727,48034,000
Upgrade
Market Cap Growth
-6.53%116.11%18.33%29.61%-19.18%-8.03%
Upgrade
Enterprise Value
112,801150,359109,242106,45699,359115,222
Upgrade
Last Close Price
55.9581.0138.1532.9926.9530.55
Upgrade
PE Ratio
----21.19-
Upgrade
PS Ratio
1.081.510.740.680.560.64
Upgrade
PB Ratio
2.624.371.441.180.790.96
Upgrade
P/FCF Ratio
20.0933.3913.909.7237.4416.58
Upgrade
P/OCF Ratio
12.8720.058.566.3711.078.70
Upgrade
EV/Sales Ratio
1.992.501.912.032.012.15
Upgrade
EV/EBITDA Ratio
7.079.327.007.637.257.77
Upgrade
EV/EBIT Ratio
9.4312.249.5411.3710.3811.73
Upgrade
EV/FCF Ratio
37.6255.1236.0329.06135.3656.18
Upgrade
Debt / Equity Ratio
2.563.182.502.522.102.40
Upgrade
Debt / EBITDA Ratio
3.583.984.535.265.195.57
Upgrade
Debt / FCF Ratio
19.6924.2824.0820.8099.9741.59
Upgrade
Asset Turnover
0.410.400.360.330.320.31
Upgrade
Inventory Turnover
2.262.412.092.082.022.02
Upgrade
Quick Ratio
0.480.500.540.570.610.51
Upgrade
Current Ratio
1.060.981.021.051.140.99
Upgrade
Return on Equity (ROE)
-2.42%-28.30%-7.36%-25.19%4.09%-31.38%
Upgrade
Return on Assets (ROA)
5.71%5.09%4.54%3.63%3.91%3.53%
Upgrade
Return on Capital (ROIC)
9.34%8.06%6.78%5.11%5.31%4.77%
Upgrade
Return on Capital Employed (ROCE)
13.20%12.70%10.20%8.20%8.40%8.20%
Upgrade
Earnings Yield
-0.88%-6.55%-4.78%-24.15%4.72%-37.73%
Upgrade
FCF Yield
4.98%3.00%7.20%10.29%2.67%6.03%
Upgrade
Buyback Yield / Dilution
-1.25%-1.07%-0.81%-0.27%-1.10%-0.37%
Upgrade
Total Shareholder Return
--1.07%-0.81%-0.27%-1.10%-0.37%
Upgrade
Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.